Stichworte Archiv: Tricuspid regurgitation

Perfusfind S.L.

Abstract Tricuspid regurgitation (TR) is common after a heart transplant and is associated with worse clinical outcomes. The incidence ranges from 34% immediately after transplant to 20% by 10 years...

Perfusfind S.L.

Abstract There is growing evidence that severe tricuspid regurgitation (TR) impacts clinical outcomes in a variety of cardiovascular disease states. The late presentation of patients with advanced TR highlights the..

Perfusfind S.L.

Abstract In February 2022, Cleveland Clinic interventional cardiologists performed the first implantation of the TricValve® Transcatheter Bicaval Valves System in a patient in North America. The successful case, completed in an..

Perfusfind S.L.

Patient with severe TR and permanently damaged SA and AV nodes due to ablation undergone TVR and two permanent epicardial pace fixation. [gallery ids="30420,30416,30412,30408,30404,30400,30396,30392"]   [playlist ids="30388"] Dr.Sam Zeraatian Nejad..

Perfusfind S.L.

Patient with severe MS and TR undergone single incision MV replacement and TV repair with modified repair technique bilateral tricuspid valve weaned from CPB uneventfully.  Dr.Sam Zeraatian Nejad Davani, CEO..

Perfusfind S.L.

Introduction The increasing burden of valvular heart disease (VHD)—in particular in an ageing population—is recognized by medical experts, although there is less awareness of these conditions by the general public..

Perfusfind S.L.

Longstanding tricuspid valve regurgitation (TR), either of functional or organic origin, might lead to severe right ventricular (RV) dilatation and/or dysfunction. The chordal shortening caused by papillary muscle displacement secondary..

Perfusfind S.L.

CABG and PM VSD and simultaneous Post MI VSD, and severe TV regurgitation undergone total correction. [playlist ids="20528"] Dr.Sam Zeraatian Nejad Davani, CEO of rockingham medical research ADKWA center as..

Perfusfind S.L.

Preamble Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing the best management strategies for an individual patient with a given condition. Guidelines and..

Perfusfind S.L.

Abstract Objectives The purpose of this study was to introduce a novel clinically relevant nomenclature system for the  and determine the relative incidence of each morphological type. Background With the rapid..

Perfusfind S.L.

Abstract Carcinoid disease is caused by neuroendocrine tumors, most often located in the gut, and leads in approximately 20% of cases to specific, severe heart disease, most prominently affecting right-sided..

Perfusfind S.L.

Abstract Introduction Pulmonary embolism (PE) is a potentially fatal disease encountered in the hospital setting. Prompt diagnosis and management can improve outcomes and survival. Unfortunately, a PE may be difficult..

Perfusfind S.L.

Preamble Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines with recommendations to improve cardiovascular health. These guidelines,..

Perfusfind S.L.

The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)